Resources

Type of publications
Regions
Diseases

5192 results found

2025 ∙ Wu, H. Li, L. Fu, K. Shen, Y. Lu, Y. Liao, Z. Liu, Y. Zha, W. Wu, L. Zhang, Y.

Effects of different-valent vaccines against human papillomavirus (HPV) to prevent persistent HPV16/18 infections and CIN2+ in women: a systematic review and network meta-analysis

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Marra, F. Gomes, K. Liu, E. Vadlamudi, N. K. Richardson, K. Cragg, J. J.

Effects of herpes zoster infection, antivirals and vaccination on risk of developing dementia: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Herpes zoster
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Henschke, N. Bergman, H. Buckley, B. S. Crosbie, E. J. Dwan, K. Golder, S. P. Kyrgiou, M. Loke, Y. K. McIntosh, H. M. Probyn, K. et al.,

Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV‐related disease and harms from vaccination

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2025 ∙ Chen, J. Zhou, W. Cen, M. Chen, C. Cao, K. Chen, M. Qu, R. Miao, J. Qi, J. Wu, X. Zhang, H. Feng, Q. Dai, A. Zhou, J. Xu, N. Hu, X. Yang, S.

Effects of influenza vaccination on neurodegenerative and demyelinating disorders: a systematic review and meta-analysis

  • All age groups
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Nimpa, M. M. Ntambue, A. Ngandu, C. Danovaro-Holliday, M. C. Bita Fouda, A. Cikomola, A. M. W. Mukendi, J. C. Mwamba, D. Aluma, A. D. L. Yapi, M. D. Nikiema, J. B. Hama Sambo, B. Ishoso, D. K.

Effects of Pneumococcal Vaccination in Children Under Five Years of Age in the Democratic Republic of Congo: A Systematic Review

  • Africa
  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Azeem, M. Cancemi, P. Mukhtar, F. Marino, S. Peri, E. Di Prima, G. De Caro, V.

Efficacy and limitations of SARS-CoV-2 vaccines - A systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Saif-Ur-Rahman, K. King, C. Whelan, S. O. Blair, M. Donohue, S. Madden, C. Kothari, K. Sommer, I. Harder, T. Dauby, N. et al.,

Efficacy and safety of respiratory syncytial virus vaccines

  • All age groups
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Moderate
2025 ∙ Gyawali, R. Poudyal, N. Docherty, A.

Efficacy and Safety of Tetanus-Toxoid Conjugate Typhoid Vaccine (Vi-TT) in Children and Adolescents: A Systematic Review and Meta-Analysis

  • Newborn
  • Children
  • Adolescents
  • Typhoid
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2025 ∙ Volonte, S. De Vicari, D. Cola, A. Barba, M. Frigerio, M.

Efficacy and Safety of Uro-Vaxom in Urinary Tract Infection Prevention: A Systematic Literature Review

  • Adults
  • Older adults
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Inauen, J. LaBroome, S. Maldari, A. Stevens, N. E. Geake, J. B. Lynn, D. J. Barry, S.

Efficacy of Bacille Calmette-Guerin Against COVID-19 Hospitalisation: A Meta-Analysis and Systematic Review of Randomised Control Trials

  • Adults
  • Older adults
  • Healthcare workers
  • Tuberculosis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
Loading...